ESMO I-O: BMS zooms in on squamous lung cancer patients as it dissects Opdivo-chemo combo failure
admin 12th December 2019 Uncategorised 0As Bristol-Myers Squibb continues to search for bright spots in its eyebrow-raising Opdivo-chemo combo fail from June, it’s zeroing in on the population of squamous lung cancer patients who seemed to benefit.
More: ESMO I-O: BMS zooms in on squamous lung cancer patients as it dissects Opdivo-chemo combo failure
Source: fierce